Q3 FY26 results up YoY; board approves raising up to Rs 700 crores

Exceptional itemResults View source PDF Explain this filing

ARTEMISMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-8.8%Reaction day

₹240.00

prior close

₹245.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+3.7%-12.5% vs market

Hospital peers, median of 22sector+1.3%-10.0% vs sector

On the reaction day the stock moved 12.5 pts less than Nifty Microcap 250 and 10.0 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-4.5

10m

-4.8

15m

-6.1

30m

-6.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-8.8+3.7-12.5+1.3-10.0

Next day

-10.3+5.1-15.4+2.0-12.3

-8.8+4.0-12.8+0.9-9.7

-9.0+3.2-12.2+0.7-9.7

-5.8+5.9-11.7+3.5-9.3

-2.1+6.9-9.0+4.7-6.8

+1.6+5.9-4.3+5.7-4.1

15d

-2.3+2.1-4.3+5.0-7.3

-3.3-3.5+0.1+1.1-4.5

-5.0-4.2-0.8-0.6-4.4

+3.4+10.9-7.6+7.4-4.0

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 22Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Artemis Medicare Services posted Q3 FY26 standalone revenue of Rs 267.12 cr (up 17.7% YoY) and PAT of Rs 22.51 cr (up 8.3%). For 9M FY26, revenue rose 16% to Rs 786.70 cr and PAT up 22.6% to Rs 73.89 cr. Board also approved raising up to Rs 700 crores via equity, debentures, QIP, preferential or private placement. Exceptional item of Rs 3.07 cr booked for Labour Codes impact.

Likely market impact

Strong revenue growth and expansion plan; possible equity dilution if QIP or preferential route is used. Watch pricing of any raise.